Harikrishna Reddy Rachamala

6PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 15, 2026
Amphiphilic Glycopolymer Nanoparticles for pH-Responsive Paclitaxel Delivery and Enhanced Efficacy in Pancreatic Ductal Adenocarcinoma Therapy.

|May 13, 2026
Targeting Glioblastoma Stem Cells: Therapeutic Strategies and Clinical Perspectives.

|May 13, 2026
Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy.

|Oct 29, 2025
Translational Advances in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons.

Hari Krishnareddy Rachamala

|Jun 24, 2024
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma.

Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla

|Mar 26, 2021
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery.

Hari Krishnareddy Rachamalla, Santanu Bhattacharya, Ajaz Ahmad

Pageof 1

Frequent Collaborators

4 joint publications

Debabrata Mukhopadhyay

3 joint publications

Santanu Bhattacharya

2 joint publications

Rajkumar Banerjee

1 joint publications

Douaa Albelal